Eylea, aflibercept solution for injection, is only recommended if administered within the National Health Service and National Institute for Health and Care Excellence guidelines.
More Articles on Ophthalmology:
AAO Issues Statement on Pharmaceutical Compounding Legislation
BIOLASE Earns US Patent for Laser Technologies
Valeant Acquires Bausch + Lomb for $8.7B
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
